Nonopioid Suzetrigine Demonstrates Positive Phase 3 Results for Acute Pain | ASA 2024
Drug Topics
OCTOBER 21, 2024
Suzetrigine could represent the first new nonopioid drug in a distinct class of pain medications in approximately 20 years.
Mon.Oct 21, 2024
386 
Embedding into the provider’s workflow is key to a specialty drug’s success
PharmaVoice
OCTOBER 21, 2024
Providers struggle with time-consuming processes. Patients are waiting for therapy. Embedded EMR system solutions can streamline therapy initiation and improve outcomes.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Rates of Opioid Use Disorder With Gabapentin, Benzodiazepine Coprescription Evaluated
Drug Topics
OCTOBER 21, 2024
Opioid use disorder risk was higher in a cohort of patients with chronic pain without disability.
FDA’s GLP-1 decision kicks off ‘unprecedented’ tussle over shortage
PharmaVoice
OCTOBER 21, 2024
After initially declaring the shortage of Eli Lilly’s diabetes and weight loss drugs over, the FDA changed its mind and re-opened the door for GLP-1 compounders.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STI Stigmatization, Misinformation in the Media | IDWeek 2024
Drug Topics
OCTOBER 21, 2024
Researchers explored the stigmatization of sexually transmitted infections across film while also identifying inaccuracies in STI-related content on Tik Tok.
Walking Together: How Pinksocks Are Inspiring Compassion and Connection in Cancer Care
Pharmacy Times
OCTOBER 21, 2024
The story of pinksocks and the inspiring movement that they launched.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
STAT+: Pharma execs donated more to Democrats in campaign’s final stretch
STAT
OCTOBER 21, 2024
WASHINGTON — Most executives at pharmaceutical companies haven’t directly donated to political candidates over the final stretch of the 2024 campaign. But those who have largely gave to Democrats. A STAT review of contributions by CEOs of member companies and board members of the brand drug lobby PhRMA showed most executives just gave to their companies’ political action committees, if they gave at all.
Education Resources Affect Pharmacy Pneumococcal Vaccination Conversations
Drug Topics
OCTOBER 21, 2024
Pharmacist education can positively impact patient counseling around vaccinations in older adults.
Dietary experts advise skipping guidelines on ultra-processed foods — for now
STAT
OCTOBER 21, 2024
If you were hoping to see where ultra-processed foods might fit in the next Dietary Guidelines for Americans, hold that thought. Scientific experts tasked with advising federal officials drafting the 2025-2030 Dietary Guidelines for Americans said the data were far too limited to draw conclusions. Meeting Monday, the first of two days of presentations, they discussed research findings to inform a report to the Department of Health and Human Services and the Department of Agriculture.
Pharmacy Screening Can Identify Depression in Older Adults
Drug Topics
OCTOBER 21, 2024
Normalizing conversations around mental health in older adult populations can improve outcomes.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT+: Former FDA lawyers join tobacco industry in ‘epic’ fight against the agency
STAT
OCTOBER 21, 2024
STAT is publishing this investigation in partnership with The Examination. Perham Gorji was a career government lawyer, helping to lead the Food and Drug Administration’s battle against tobacco and e-cigarettes. He was there as the agency contemplated a ban on menthol cigarettes, and as vapes of all shapes and sizes flooded the market, hooking a new generation on nicotine.
Q&A: What Pharmacists Need to Know about Onyda XR for the Treatment of ADHD
Drug Topics
OCTOBER 21, 2024
A conversation with Rakesh Jain, MD, MPH, clinical professor in the Department of Psychiatry at Texas Tech University School of Medicine.
STAT+: Perplexing results from Duchenne muscular dystrophy trial raise questions about gene therapies
STAT
OCTOBER 21, 2024
Confounding data from a Pfizer clinical trial has rattled the field of gene therapy for Duchenne muscular dystrophy, raising more questions about the regulatory standard used to approve a treatment from Sarepta Therapeutics, and complicating plans for other companies hoping to develop next-generation products. Scientifically, Pfizer’s gene therapy did what it was supposed to do.
How AI can manage the risks and costs of postmarketing requirements
PharmaVoice
OCTOBER 21, 2024
PMRs are not new but drug developers can use AI to predict risk and manage costs earlier in studies.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
After shingles damaged her vision, this former eye surgeon looked for a way to keep it from happening to others
STAT
OCTOBER 21, 2024
It began with a burning pain in her right eye. At first, Elisabeth Cohen thought she’d gotten something in it. But the next day, as she was pushing her hair back on that side of her head, she noticed a blister near the hairline. She knew immediately what it was: shingles. At the time, in 2008, Cohen was director of the Cornea Service at Wills Eye Hospital in Philadelphia.
Amazon One Medical, Cleveland Clinic to open primary care clinics in Northeast Ohio
Fierce Healthcare
OCTOBER 21, 2024
Academic health system Cleveland Clinic is teaming up with an industry disruptor to expand primary care services in Northeast Ohio. | Academic health system Cleveland Clinic is teaming up with an industry disruptor to expand primary care services in Northeast Ohio.
A telling chart shows how health insurers found a way to boost profits by limiting care for seniors
STAT
OCTOBER 21, 2024
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine. Sign up to get it in your inbox every Monday. The ‘#1 PRIORITY’ The emails from inside a physician practice owned by UnitedHealth Group sounded cheery, but were all business.
American Pharmacists Month: Frank Kessler Reflects on Decades of Work in Community Pharmacy
Pharmacy Times
OCTOBER 21, 2024
A dedicated community pharmacist for over 40 years, Kessler has witnessed immense change and innovation throughout his career.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Philadelphia-area health systems end use of four race-based algorithms to guide care
STAT
OCTOBER 21, 2024
A coalition of 12 Philadelphia-area health systems announced Monday that its members have abandoned the use of race adjustments in four clinical tools commonly used to guide care, a move that health leaders say will improve treatment and prevent delays in diagnosis for Black, Hispanic, and Asian patients. The decision marks one of the largest and broadest efforts to date to remove race from widely used clinical algorithms.
FDA Approves Companion Diagnostic To Identify Patients With Grade 2 IDH-Mutant Glioma Eligible for Vorasidenib
Pharmacy Times
OCTOBER 21, 2024
The diagnostic test is a companion to vorasidenib, an isocitrate dehydrogenase inhibitor that received FDA approval this past summer.
STAT+: Behind CVS CEO’s ouster, a question: Do a pharmacy and a health insurer make sense together?
STAT
OCTOBER 21, 2024
Does it make sense for a chain of drug stores to own a major health insurance company? That has been the existential question for CVS Health for six years, since its $70 billion acquisition of the massive insurer Aetna. The biggest pharmacy chain in the U.S. had already been moving beyond retail since its 2007 deal for pharmacy benefit manager Caremark.
Gilead, MSD say HIV combo could be weekly, oral HIV drug
pharmaphorum
OCTOBER 21, 2024
An antiretroviral combination developed by Gilead and MSD suppressed HIV with a single weekly oral dose in a phase 2 trial reported at IDWeek 2024
Using AI, images are fueling a new boom in cell biology
STAT
OCTOBER 21, 2024
Compared to molecular techniques to study single cells, images feel a little like “old school biology,” says Anne Carpenter, an artificial intelligence and cell biology researcher at the Broad Institute. Yet images are a gold mine that can yield information as rich as the genome — once you learn how to extract it. Carpenter is using AI and other computational methods to do exactly that, helping to propel an AI-driven boom in cell biology and medicine over the pas
HLTH24: GE Healthcare unveils iPhone-like AI platform, CareIntellect
Fierce Healthcare
OCTOBER 21, 2024
LAS VEGAS – GE Healthcare unveiled its new generative AI platform, CareIntellect, on stage at HLTH 2024 on Monday. The first application available on the platform is for oncology. | GE Healthcare aims to make integrating generative AI into healthcare delivery less clunky through its new CareIntellect platform, which will eventually host a range of clinical and operational AI solutions.
PursueCare brings Pear addiction DTx apps back to life
pharmaphorum
OCTOBER 21, 2024
Two digital therapeutics for addiction are available again through PursueCare, which acquired them from now-defunct Pear Tx last year
HLTH24 Day 2: Google Cloud, Recursion expand tech partnership; HealthEx raises $14M
Fierce Healthcare
OCTOBER 21, 2024
LAS VEGAS—Recursion and Google Cloud have expanded their tech partnership to use cloud technologies to power Rcursion's drug discovery platform. | On the second day of HLTH, Recursion announced it was deepening its partnership with Google Cloud and HealthEx unveiled a $14 million funding round.
Morning Rounds: RFK fears, an ‘epic’ FDA fight, Marburg update
STAT
OCTOBER 21, 2024
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Have you ever seen an award-winning journalist sing karaoke? After the Summit ended last week, a big group of STAT staffers belted and crooned together for hours and my heart has never been so full. It was all deeply off the record so I can’t tell you who sang what.
HLTH24: Blue Shield of California, Salesforce join forces to streamline prior authorization
Fierce Healthcare
OCTOBER 21, 2024
LAS VEGAS — Blue Shield of California and Salesforce are teaming up to simplify and streamline the prior authorization experience. | LAS VEGAS — Blue Shield of California and Salesforce are teaming up to simplify and streamline the prior authorization experience.
Seaport docks $225m for its improved neuropsychiatry drugs
pharmaphorum
OCTOBER 21, 2024
Seaport Therapeutics completes a $225m Series B to fund its improved therapies for depression and anxiety, just months after raising $100m on its debut
Humana joins chorus of lawsuits over sinking star ratings
Fierce Healthcare
OCTOBER 21, 2024
Humana, one the country’s largest Medicare Advantage organizations, is suing the Centers for Medicare & Medicaid Services over its 2025 star | Humana, one the country’s largest Medicare Advantage organizations, is suing the Centers for Medicare & Medicaid Services over its 2025 star ratings results.
STAT+: Catalent tries to reassure customers about its deal with Novo Holdings
STAT
OCTOBER 21, 2024
Catalent, a leading contract drug manufacturer, issued an open letter on Monday to reassure customers that a proposed $16.5 billion deal — in which it would be acquired by Novo Nordisk’s parent — will not raise competitive concerns or diminish its ability to provide services to other drug companies. Catalent is an attractive buyout target for Novo Holdings — which owns 77% of the voting shares in the drugmaker — because it is currently a subcontractor that
US government proposes birth control, HIV preventive service protections
Fierce Healthcare
OCTOBER 21, 2024
With just 15 days until the presidential election, the federal government is proposing new rules that aim to bolster protections around birth control and other preventive services. | The U.S. federal government is attempting to ease access to birth control products and HIV prevention drugs in a newly proposed rule.
The biotech updates you need to read this morning
STAT
OCTOBER 21, 2024
This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Morning! Today, we discuss why disappointing data from Pfizer’s Duchenne muscular dystrophy trial might spell trouble for others developing gene therapies for the condition.
Let's personalize your content